Quest Diagnostics EPS - Earnings per Share 2010-2024 | DGX
Quest Diagnostics annual and quarterly earnings per share history from 2010 to 2024. Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
- Quest Diagnostics EPS for the quarter ending September 30, 2024 was $1.99, a 1.53% increase year-over-year.
- Quest Diagnostics EPS for the twelve months ending September 30, 2024 was $7.44, a 10.88% increase year-over-year.
- Quest Diagnostics 2023 annual EPS was $7.49, a 6.02% decline from 2022.
- Quest Diagnostics 2022 annual EPS was $7.97, a 48.75% decline from 2021.
- Quest Diagnostics 2021 annual EPS was $15.55, a 48.52% increase from 2020.
| Quest Diagnostics Annual EPS |
| 2023 |
$7.49 |
| 2022 |
$7.97 |
| 2021 |
$15.55 |
| 2020 |
$10.47 |
| 2019 |
$6.28 |
| 2018 |
$5.29 |
| 2017 |
$5.50 |
| 2016 |
$4.51 |
| 2015 |
$4.87 |
| 2014 |
$3.81 |
| 2013 |
$5.54 |
| 2012 |
$3.46 |
| 2011 |
$2.92 |
| 2010 |
$4.05 |
| 2009 |
$3.87 |
| Quest Diagnostics Quarterly EPS |
| 2024-09-30 |
$1.99 |
| 2024-06-30 |
$2.03 |
| 2024-03-31 |
$1.72 |
| 2023-12-31 |
$1.70 |
| 2023-09-30 |
$1.96 |
| 2023-06-30 |
$2.05 |
| 2023-03-31 |
$1.78 |
| 2022-12-31 |
$0.92 |
| 2022-09-30 |
$2.17 |
| 2022-06-30 |
$1.96 |
| 2022-03-31 |
$2.92 |
| 2021-12-31 |
$3.11 |
| 2021-09-30 |
$4.02 |
| 2021-06-30 |
$4.96 |
| 2021-03-31 |
$3.46 |
| 2020-12-31 |
$4.24 |
| 2020-09-30 |
$4.14 |
| 2020-06-30 |
$1.36 |
| 2020-03-31 |
$0.73 |
| 2019-12-31 |
$1.86 |
| 2019-09-30 |
$1.56 |
| 2019-06-30 |
$1.66 |
| 2019-03-31 |
$1.20 |
| 2018-12-31 |
$0.92 |
| 2018-09-30 |
$1.53 |
| 2018-06-30 |
$1.57 |
| 2018-03-31 |
$1.27 |
| 2017-12-31 |
$1.82 |
| 2017-09-30 |
$1.15 |
| 2017-06-30 |
$1.37 |
| 2017-03-31 |
$1.16 |
| 2016-12-31 |
$1.09 |
| 2016-09-30 |
$1.34 |
| 2016-06-30 |
$1.37 |
| 2016-03-31 |
$0.71 |
| 2015-12-31 |
$1.29 |
| 2015-09-30 |
$2.35 |
| 2015-06-30 |
$0.81 |
| 2015-03-31 |
$0.42 |
| 2014-12-31 |
$1.30 |
| 2014-09-30 |
$0.88 |
| 2014-06-30 |
$0.92 |
| 2014-03-31 |
$0.71 |
| 2013-12-31 |
$0.94 |
| 2013-09-30 |
$2.68 |
| 2013-06-30 |
$1.07 |
| 2013-03-31 |
$0.85 |
| 2012-12-31 |
$0.35 |
| 2012-09-30 |
$1.01 |
| 2012-06-30 |
$1.11 |
| 2012-03-31 |
$0.99 |
| 2011-12-31 |
$1.16 |
| 2011-09-30 |
$1.07 |
| 2011-06-30 |
$1.02 |
| 2011-03-31 |
$-0.33 |
| 2010-12-31 |
$0.96 |
| 2010-09-30 |
$1.13 |
| 2010-06-30 |
$1.07 |
| 2010-03-31 |
$0.89 |
| 2009-12-31 |
$0.97 |
| 2009-09-30 |
$1.02 |
| 2009-06-30 |
$1.00 |
| 2009-03-31 |
$0.88 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$17.349B |
$9.252B |
|
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
|
